France versus Germany: differences and similarities in determining the added therapeutic value of medicines.

Kilwing P, Dintsios CM

Open source

DOI
10.1007/s10198-026-01911-w
Published
2026 Apr 15
Container
The European journal of health economics : HEPAC : health economics in prevention and care
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10198-026-01911-w,
  title = {France versus Germany: differences and similarities in determining the added therapeutic value of medicines.},
  author = {Kilwing P and Dintsios CM},
  year = {2026},
  journal = {The European journal of health economics : HEPAC : health economics in prevention and care},
  doi = {10.1007/s10198-026-01911-w},
  url = {https://doi.org/10.1007/s10198-026-01911-w}
}

RIS

TY  - JOUR
TI  - France versus Germany: differences and similarities in determining the added therapeutic value of medicines.
AU  - Kilwing P
AU  - Dintsios CM
PY  - 2026
JO  - The European journal of health economics : HEPAC : health economics in prevention and care
DO  - 10.1007/s10198-026-01911-w
UR  - https://doi.org/10.1007/s10198-026-01911-w
ER  - 

APA

P, K., & CM, D. (2026). France versus Germany: differences and similarities in determining the added therapeutic value of medicines.. The European journal of health economics : HEPAC : health economics in prevention and care. https://doi.org/10.1007/s10198-026-01911-w

Source records